Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Psoriasis × secukinumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 1 Periodic Fevers Syndrome 1 Motor Activity 1 Lymphoma, Follicular 1 Crohn Disease 1 Arthritis, Rheumatoid 1

Interventions

tofacitinib 7 Etanercept 3 deucravacitinib 2 Methotrexate 2 Adalimumab 2 sotrastaurin 1 secukinumab 1 calcipotriene 1 baricitinib 1 apremilast 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01961609 2019-03-18

SIGNATURE

Novartis

Phase 3 Completed

235 enrolled 23 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡